SCREEN PHARMA SERVICES LTD

SCREEN PHARMA SERVICES LTD

Company Registration Number:
NI066713 (Northern Ireland)

Unaudited abridged accounts for the year ended 31 December 2017

Period of accounts

Start date: 01 January 2017

End date: 31 December 2017

SCREEN PHARMA SERVICES LTD

Contents of the Financial Statements

for the Period Ended 31 December 2017

Balance sheet
Notes

SCREEN PHARMA SERVICES LTD

Balance sheet

As at 31 December 2017


Notes

2017

2016


£

£
Fixed assets
Intangible assets:   0 0
Tangible assets: 2 185 379
Investments:   0 0
Total fixed assets: 185 379
Current assets
Stocks: 0 0
Debtors:   10,175 1,262
Cash at bank and in hand: 40,283 74,513
Investments:   0 0
Total current assets: 50,458 75,775
Creditors: amounts falling due within one year: 3 (9,439) (30,215)
Net current assets (liabilities): 41,019 45,560
Total assets less current liabilities: 41,204 45,939
Creditors: amounts falling due after more than one year:   0 0
Provision for liabilities: 0 0
Total net assets (liabilities): 41,204 45,939
Capital and reserves
Called up share capital: 100 100
Share premium account: 0 0
Revaluation reserve: 00
Other reserves: 0 0
Profit and loss account: 41,104 45,839
Shareholders funds: 41,204 45,939

The notes form part of these financial statements

SCREEN PHARMA SERVICES LTD

Balance sheet statements

For the year ending 31 December 2017 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with Section 444(2A).

These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The directors have chosen to not file a copy of the company’s profit & loss account.

This report was approved by the board of directors on 24 August 2018
and signed on behalf of the board by:

Name: Michael O'Neill
Status: Director

The notes form part of these financial statements

SCREEN PHARMA SERVICES LTD

Notes to the Financial Statements

for the Period Ended 31 December 2017

1. Accounting policies

These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

SCREEN PHARMA SERVICES LTD

Notes to the Financial Statements

for the Period Ended 31 December 2017

2. Tangible Assets

Total
Cost £
At 01 January 2017 3,813
Additions 0
Disposals 0
Revaluations 0
Transfers 0
At 31 December 2017 3,813
Depreciation
At 01 January 2017 3,434
Charge for year 194
On disposals 0
Other adjustments 0
At 31 December 2017 3,628
Net book value
At 31 December 2017 185
At 31 December 2016 379

SCREEN PHARMA SERVICES LTD

Notes to the Financial Statements

for the Period Ended 31 December 2017

3. Creditors: amounts falling due within one year note

Included in Creditors: amounts due within one year is an amount of £ 7,934 owing to director, Michael O'Neill. This is interest-free and repayable on demand.

SCREEN PHARMA SERVICES LTD

Notes to the Financial Statements

for the Period Ended 31 December 2017

4. Loans to directors

Name of director receiving advance or credit: Michael O'Neill
Description of the loan: Loan advance to the company
£
Balance at 01 January 2017 19,986
Advances or credits repaid: 12,052
Balance at 31 December 2017 7,934

SCREEN PHARMA SERVICES LTD

Notes to the Financial Statements

for the Period Ended 31 December 2017

5. Related party transactions

Name of the related party: Screen Clinical Limited
Relationship:
Screen Clinical Limited is a company wholly owned and controlled by director, Michael O'Neill
Description of the Transaction: Loan to Screen Clinical Limited
£
Balance at 01 January 2017 0
Balance at 31 December 2017 8,475